“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."
The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients. The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here.
Kinsie Clarkson: Feb 12, 2025
A new study published by the AHA shows the use of AI and communication tools decreases treatment times between 43% and 53% for door-to-CT,...
Dale Pearson: Feb 05, 2025
At Pulsara, our commitment to improving the lives of people and those who serve them drives everything we do. We are proud of the intentional culture...
Audrey Peart: Jan 29, 2025
January Recap During the first month of 2025, our teams traveled to California for the NAEMSP Annual Meeting, Florida for the Florida Fire...
Brittney Nelson, BSN, RN, SCRN